CBD Topicals vs CBD Oil: What are the Key Differences?

CBD (cannabidiol) is a non-psychoactive compound found in the cannabis plant that has gained popularity for its potential therapeutic effects for a range of conditions. Two popular methods of using CBD are topically and orally through oil tinctures. While both methods can offer benefits, they work differently and have unique considerations.

CBD Topicals:

CBD topicals are applied to the skin and are designed to be absorbed through the skin to provide localized relief. Topical applications are usually formulated with other ingredients that can provide additional benefits to the skin, such as moisturization, exfoliation, or cooling effects. Some examples of CBD topicals include balms, salves, creams, lotions, and transdermal patches.

How CBD Topicals Work:

When CBD is applied topically, it interacts with the endocannabinoid system (ECS) receptors in the skin. The ECS is a complex system of receptors and chemicals that regulate various physiological processes, including pain, inflammation, and immunity. CBD can activate these receptors, which can help to reduce inflammation and pain in the localized area where the topical is applied.

Types of CBD Topicals:

There are several types of CBD topicals available on the market, each with its unique formulation and delivery method. Some of the most common types of CBD topicals include:

Balms and Salves: These products are thick and often contain a high concentration of CBD. They are intended for use on specific areas of the body and are usually rubbed into the skin.

Creams and Lotions: These products are lighter than balms and salves and are designed to be applied to larger areas of the body. They often contain other beneficial ingredients, such as aloe vera or vitamin E.

Transdermal Patches: These patches are applied directly to the skin and can provide long-lasting relief. They contain a higher concentration of CBD than other topicals, allowing for a more potent effect.

Safety of CBD Topicals:

CBD topicals are generally considered safe, as they are not typically absorbed into the bloodstream and are unlikely to produce systemic effects throughout the body. However, some individuals may experience mild side effects, such as skin irritation or allergic reactions, particularly if they have sensitive skin or are allergic to any of the ingredients in the product. It is important to read the label carefully and follow the instructions provided by the manufacturer to minimize the risk of adverse reactions.

Types of CBD Oil:

CBD oil is extracted from the hemp plant and can be ingested orally. There are several types of CBD oil, each with its unique benefits and uses. Some of the most common types of CBD oil include:

Full-Spectrum CBD Oil: This type of oil contains all of the compounds found in the hemp plant, including THC (tetrahydrocannabinol). While THC is psychoactive, the concentration is typically low enough that it will not produce a high.

Broad-Spectrum CBD Oil: This type of oil contains all of the compounds found in the hemp plant, except for THC.

CBD Isolate: This type of oil contains only CBD and no other compounds found in the hemp plant.

Safety of CBD Oils:

CBD oils are generally considered safe when used as directed, but they may interact with certain medications or medical conditions. CBD can inhibit the activity of liver enzymes that metabolize some medications, which can increase the concentration of these medications in the bloodstream and potentially cause adverse effects. It is important to consult with a healthcare provider before using CBD oils if you are taking any medications or have any medical conditions.

CBD Topical Application:

When applying a CBD topical, it is important to clean the area of skin where the product will be applied. Once the area is clean and dry, the topical should be massaged into the skin until it is fully absorbed. The amount of topical needed will vary depending on the concentration of CBD and the size of the area being treated.

CBD Oil Ingestion:

CBD oil can be ingested orally by placing drops under the tongue or by adding it to food or drinks. The amount of oil needed will vary depending on the concentration of CBD and the desired effects. It is important to start with a low dose and gradually increase until the desired effects are achieved.

CBD Topical Absorption:

When a CBD topical is applied to the skin, it is absorbed into the skin and underlying tissues. The rate of absorption will depend on the concentration of CBD, the formulation of the product, and the area of the body where the product is applied. Topicals are not typically absorbed into the bloodstream, so they are less likely to produce systemic effects throughout the body.

CBD Oil Bioavailability:

When CBD oil is ingested orally, it must pass through the digestive system before being absorbed into the bloodstream. This process can take up to two hours and can reduce the bioavailability of the CBD, which is the amount of CBD that actually enters the bloodstream and produces effects. Some studies have found that the bioavailability of orally ingested CBD can range from 4% to 20%, depending on the individual and the formulation of the product.

Conclusion:

CBD topicals and oils have shown potential, but more research is needed to determine their safety and efficacy. While CBD topicals are generally considered safe and well-tolerated, they are unlikely to produce systemic effects throughout the body. CBD oils are also generally considered safe when used as directed, but they may interact with certain medications or medical conditions. The bioavailability of CBD topicals and oils can vary depending on the concentration of CBD, the formulation of the product, and the method of administration. It is important to consult with a healthcare provider before using CBD for therapeutic purposes and to carefully follow the instructions provided by the manufacturer of the product.

CBD topicals and CBD oil are two popular methods of using CBD for potential therapeutic effects. CBD topicals are applied to the skin and are designed to provide localized relief, while CBD oil is ingested orally and can produce systemic effects throughout the body. Both methods have their unique considerations, such as bioavailability and absorption rates. It is important to consult with a healthcare provider before using CBD for therapeutic purposes and to carefully follow the instructions provided by the manufacturer of the product.

Research citations:

Russo, E. B. (2016). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management, 12, 389-400. doi: 10.2147/TCRM.S119953

Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. European Journal of Pain, 20(6), 936-948. doi: 10.1002/ejp.818

Millar, S. A., Stone, N. L., Bellman, Z. D., Yates, A. S., England, T. J., & O’Sullivan, S. E. (2019). A systematic review of cannabidiol dosing in clinical populations. British Journal of Clinical Pharmacology, 85(9), 1888-1900. doi: 10.1111/bcp.14038

Baron, E. P. (2018). Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: An update on current evidence and cannabis science. Headache, 58(7), 1139-1186. doi: 10.1111/head.13345

Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770-1804. doi: 10.1002/cbdv.200790152

Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. Journal of Pain and Symptom Management, 39(2), 167-179. doi: 10.1016/j.jpainsymman.2009.06.008

Fernández-Ruiz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R., Mechoulam, R., & Martínez-Orgado, J. (2013). Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology, 75(2), 323-333. doi: 10.1111/j.1365-2125.2012.04341.x

Stott, C. G., White, L., Wright, S., Wilbraham, D., & Guy, G. W. (2013). A phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. SpringerPlus, 2(1), 236. doi: 10.1186/2193-1801-2-236